Article
US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies
Rating:
0.0
Views:
78
Likes:
1
Library:
1
The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of long COVID.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value